Skip to main content
. 2018 Aug 18;100(2):479–494. doi: 10.1093/biolre/ioy186

Figure 5.

Figure 5.

Rosiglitazone prevents the cytosolic release of cytochrome C and decreases its interaction with APAF1 under H/R condition. (A) The expression of cytochrome C in the cytosol and mitochondrion fractions isolated from JEG-3 cells exposed to H/R and rosiglitazone in comparison to normoxia (20% O2) condition. COX IV, an inner membrane protein is used for control of mitochondrial protein loading and GAPDH used for total cell lysate loading. (B) Proximity ligation assay (PLA) showing the interaction between cytochrome C and APAF1 (red dots). Negative control (negative) imaged cells processed after treatment with rosiglitazone (Rosi.) without primary antibodies. N = 3; scale bar = 100 μm.